Quarterly report pursuant to Section 13 or 15(d)

Other current assets (Details)

v3.24.3
Other current assets (Details)
$ in Thousands, £ in Millions
Jan. 19, 2024
USD ($)
Jan. 19, 2024
GBP (£)
Sep. 30, 2024
USD ($)
Dec. 31, 2023
USD ($)
Other current assets        
Research and development credits receivable     $ 24,905 $ 46,098
Prepayments     14,164 9,954
Clinical materials     97 1,329
VAT receivable     1,209  
Other current assets     3,375 2,412
Total     $ 43,750 $ 59,793
Research & Development Tax Credits        
Other current assets        
Amount of receivable from Research and Development credits $ 30,800 £ 24.2